ÂÜÀòÂÒÂ×

Victor Steien has extensive experience in finance and investment banking, currently serving as a Partner at Impilo since August 2018. In addition, Victor holds multiple board member positions at VaccinDirekt, Pelago Bioscience AB, Blodtrycksdoktorn, and Stille AB, alongside serving as a Board Observer at LOWENCO and Scantox. Prior to these roles, Victor was affiliated with Mallax Pharmaceuticals AB as a Board Member and held various positions at Morgan Stanley from 2014 to 2018, culminating as an Executive Director in Nordic M&A. Earlier experience includes working as an Associate in M&A at Goldman Sachs from 2012 to 2014. Victor holds a Master’s degree in Economics and Business Administration from the Stockholm School of Economics, obtained in 2008.